EUVIMEDEUVIMED entdecken
Open Access

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

David J Einstein iD, Meredith M Regan, Julia S Stevens, David F McDermott, Ravi A Madan

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.24.00279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von David J Einstein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Prostatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

What is most important to patients with BCR prostate cancer? Metastasis-free versus treatment-free survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalProstatic NeoplasmsHumansMaleProstate-Specific AntigenDisease-Free SurvivalRandomized Controlled Trials as TopicProstatic Neoplasms, Castration-Resistant

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.
  • Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA.
  • Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

ORCID-Profile: David J Einstein

Förderung

  • Intramural NIH HHS

Zitieren

APA

Einstein, D. J., Regan, M. M., Stevens, J. S., McDermott, D. F., & Madan, R. A. (2024). Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00279

Vancouver

Einstein DJ, Regan MM, Stevens JS, McDermott DF, Madan RA. Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00279

BibTeX
@article{Einstein2024,
  author = {Einstein, David J and Regan, Meredith M and Stevens, Julia S and McDermott, David F and Madan, Ravi A},
  title = {Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.24.00279}
}
Kostenlos starten →